Position in ACB
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$44
-$8 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 149 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Key Financial Inc holds $225,235 across 11 Drug Manufacturers - Specialty & Generic names. ACB ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
5,716 | $90,770 | |
| 2 | ZTS |
Zoetis Inc.
|
899 | $64,602 | |
| 3 | HROW |
Harrow, Inc.
|
750 | $31,852 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
710 | $10,287 | |
| 5 | HLN |
Haleon plc
|
1,000 | $9,330 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
180 | $6,516 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
34 | $5,730 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
122 | $5,674 |
All Filings in ACB
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44 | 16 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $52 | 16 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $66 | 16 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $94 | 16 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $66 | 16 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $52 | 12 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $51 | 12 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $70 | 12 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $55 | 12 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $52 | 12 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $19 | 41 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $23 | 41 | Shares | Sole | 2023-11-01 | |
| No filing history on record for this holder in this stock. | ||||||